Resveratrol inhibits aggregation of platelets from high-risk cardiac patients with aspirin resistance.
Resveratrol inhibits aggregation of platelets from high-risk cardiac patients with aspirin resistance. J Cardiovasc Pharmacol. 2006 Aug; 48(2):1-5.